Home > Boards > US Listed > Medical - Healthcare > Second Sight Medical Products Inc (EYES)

Notice of Delisting or Failure to Satisfy a

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Big Barnie Member Profile
 
Followed By 2
Posts 893
Boards Moderated 1
Alias Born 07/11/13
160x600 placeholder
Notice of Effectiveness (effect) Edgar (US Regulatory) - 6/15/2021 6:44:06 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/10/2021 1:09:20 PM
UiPath, Campbell among premarket losers' pack Seeking Alpha - 6/9/2021 8:25:44 AM
Second Sight Medical files for $250 million mixed securities shelf offering Seeking Alpha - 6/9/2021 6:55:08 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 6/8/2021 5:01:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/3/2021 6:04:01 AM
Second Sight Medical Products Announces Results of its 2021 Annual Meeting Business Wire - 6/1/2021 6:00:00 AM
Second Sight Medical trades higher on news of patent win Seeking Alpha - 5/21/2021 12:16:58 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/13/2021 6:03:48 AM
Second Sight Medical Products Announces Year Three NIH Funding of Its Orion Study Business Wire - 5/13/2021 6:00:00 AM
Second Sight Medical reports two-year results of its Orion study Seeking Alpha - 5/12/2021 6:25:26 AM
Second Sight Medical Products Announces Two-Year Results of its Orion Study Business Wire - 5/12/2021 6:00:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/30/2021 5:25:08 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 4/29/2021 6:16:20 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/27/2021 5:40:31 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 4/27/2021 4:10:30 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 4/22/2021 4:42:52 PM
Second Sight slips 8% on launch of stock offering Seeking Alpha - 4/16/2021 8:34:12 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 4/16/2021 6:02:07 AM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 4/7/2021 6:02:22 AM
Second Sight Medical Products Names Dean Baker and Alexandra Larson to its Board of Directors Business Wire - 4/6/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/6/2021 6:29:23 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/5/2021 9:19:25 AM
Second Sight Medical terminates business combination with Pixium Vision Seeking Alpha - 4/3/2021 9:13:41 PM
Second Sight Medical appoints new acting CEO Seeking Alpha - 4/1/2021 1:29:12 PM
Big Barnie   Thursday, 06/04/20 07:39:47 AM
Re: None
Post # of 1174 
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard.



Letter from Nasdaq dated June 1, 2020



On June 1, 2020, The Nasdaq Stock Market (“Nasdaq”) notified Second Sight Medical Products, Inc. (the “Company”) that following the resignation of William J. Link, effective May 31, 2020, the Company is non-compliant with Nasdaq’s independent director and audit committee requirements as set forth in Listing Rule 5605 (the “Listing Rules”) due to more than one vacancy on its board and audit committee. Nasdaq had previously notified the Company on April 15, 2020 that due to the appointment of Matt Pfeffer as Acting Chief Executive Officer of the Company, the Company no longer complied with the Listing Rules and that consistent with Listing Rules 5605(b)(1)(A) and 5605(c)(4) the Company was provided with a cure period in which to regain compliance. As a result, Nasdaq indicated that the Company is no longer eligible for the cure period and must submit a plan of compliance no later than July 16, 2020, which is 45 days after the notification date. If the plan is accepted, the Company can be granted an extension of up to 180 calendar days from the notification date to evidence compliance. If the plan is not accepted, the Company may appeal before a Nasdaq Hearing Panel.


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences